Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing
- Mini Kamboj
- Jennifer Brite
- Anoshe Aslam
- Jessica Kennington
- N. Esther Babady
- David Calfee
- Yoko Furuya
- Donald Chen
- Michael Augenbraun
- Belinda Ostrowsky
- Gopi Patel
- Monica Mircescu
- Vivek Kak
- Roman Tuma
- Teresa A. Karre
- Deborah A. Fry
- Yola P. Duhaney
- Amber Moyer
- Denise Mitchell
- Sherry Cantu
- Candace Hsieh
- Nancy Warren
- Stacy Martin
- Jill Willson
- Jeanne Dickman
- Julie Knight
- Kim Delahanty
- Annemarie Flood
- Jennifer Harrington
- Deborah Korenstein
- Janet Eagan
- Kent Sepkowitz
Publication date
March 2018
DOI Publisher
Centers for Disease Control and Prevention (CDC) Journal
Emerging Infectious DiseasesAbstract
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency
Add to ORKG